Day 3 of INTEREST 2021 is dedicated to the late Prof. Charles Boucher, who sadly passed away in February of this year.
Alongside the late Dr. Joep Lange, Charles founded the INTEREST conference in 2007 to bring together a multidisciplinary team of experts who could share knowledge and establish partnerships with the ultimate aim of improving the life quality of people living with HIV across the African continent.
The third day of this year's conference will feature memorial lectures
focusing on HIV epidemiological trends, the evolution of HIV treatment to
date and changes in how HIV healthcare services are being delivered in the
region. Delegates can expect to take part in interactive sessions exploring the
management of drug resistance, virological failure and the future of PrEP
in Africa.
Charles' love for teaching, particularly in regards to educating
young researchers, was well known. This final day of INTEREST 2021 features a
mentorship session, with the day specifically targeted towards young
investigators.
We invite you to join us in honouring Charles' memory at INTEREST 2021 and
contributing to the cross-disciplinary discussion on HIV treatment,
pathogenesis and prevention throughout Africa.The third day of this year's conference will feature memorial lectures
focusing on HIV epidemiological trends, the evolution of HIV treatment to
date and changes in how HIV healthcare services are being delivered in the
region. Delegates can expect to take part in interactive sessions exploring the
management of drug resistance, virological failure and the future of PrEP
in Africa.
Charles' love for teaching, particularly in regards to educating
young researchers, was well known. This final day of INTEREST 2021 features a
mentorship session, with the day specifically targeted towards young
investigators.
We invite you to join us in honouring Charles' memory at INTEREST 2021 and
contributing to the cross-disciplinary discussion on HIV treatment,
pathogenesis and prevention throughout Africa.
To register visit https://virology.eventsair.com/interest-2021/registration/Site/Register
EDCTP Career Development Fellow Dr Virginie Rozot, a research officer at the South African Tuberculosis Vaccine Initiative (SATVI), has been awarded a multi‑year contract under Wellcome Leap’s Delta Tissue (∆T) programme. Her research will investigate how the human immune system responds to Mycobacterium tuberculosis in the thoracic lymph nodes, and why these responses sometimes fail, allowing the bacteria to spread to other organs. The findings are expected to inform future TB vaccine design and vaccination strategies.
Global Health EDCTP3 is now inviting applications for the EDCTP Prizes 2027, recognising outstanding individuals and research teams from Africa and Europe for their achievements in global health research and innovation.
The 2027 edition will award four prize categories, highlighting excellence in scientific leadership, collaborative team research, and gender-balanced scientific contributions. Prize winners will be announced at the EDCTP Forum 2027 in Madrid, Spain. Submissions are open until 2 September 2026.
Global Health EDCTP3 has opened the calls for abstracts, scientific symposia and workshops for the EDCTP Forum 2027, one of the leading global health research events focused on infectious diseases in sub-Saharan Africa. The deadline for submissions is 2 September 2026 at 17:00 (Brussels time).
Under the theme ‘Innovating together for resilient global health', the 13th edition of the EDCTP Forum, taking place from 5-9 April 2027 in Madrid, Spain, will offer researchers, policymakers, funders and implementers the opportunity to showcase their work at a flagship global health event.
The Forum offers a unique platform to share research findings, build partnerships and help shape discussions on global health priorities. Currently, submissions for abstracts, scientific symposia and workshops are open.